# Detection of Factor V Leiden G1691A and Factor II (Prothrombin) G20210A Point Mutations in DNA

> **NCT00959504** · — · COMPLETED · sponsor: **Illumina, Inc.** · enrollment: 275 (actual)

## Conditions studied

- Detection and Genotyping of Factor V and Factor II Point Mutations

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00959504
- **Lead sponsor:** Illumina, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 275 (ACTUAL)
- **Last updated:** 2011-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00959504

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00959504, "Detection of Factor V Leiden G1691A and Factor II (Prothrombin) G20210A Point Mutations in DNA". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00959504. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*